(NASDAQ: NMTC) Neuroone Medical Technologies's forecast annual revenue growth rate of 38.03% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.59%, and it is also forecast to beat the US market's average forecast revenue growth rate of 15.36%.
Neuroone Medical Technologies's revenue in 2026 is $8,716,160.On average, 4 Wall Street analysts forecast NMTC's revenue for 2026 to be $586,101,542, with the lowest NMTC revenue forecast at $520,165,119, and the highest NMTC revenue forecast at $649,360,088. On average, 4 Wall Street analysts forecast NMTC's revenue for 2027 to be $768,803,540, with the lowest NMTC revenue forecast at $624,198,142, and the highest NMTC revenue forecast at $914,116,302.
In 2028, NMTC is forecast to generate $1,174,022,020 in revenue, with the lowest revenue forecast at $1,127,942,312 and the highest revenue forecast at $1,208,531,274.